Answers are grounded in this paper and cite their sources.
This article explores the key assumptions that underpin the National Institute for Health and Clinical Excellence's (NICE) approach to guideline development and describes how those assumptions have led to the current reduction in the range of available therapies in primary care. This reduction, it is argued, conflicts with the government's recent commitment to increase patient choice. It is suggested that we are witnessing a paradigm war between those who seek to treat psychotherapy and counselling as if it was a drug and those who regard it fundamentally as a dialogue. Further, it is contended that though NICE may acknowledge the serious debates concerning the relevance and appropriateness of its approach, by subjecting issues of mental well-being to a biomedical model of research it is effectively ignoring those debates. NICE's process is deconstructed and areas of contradiction and ambiguity within NICE's own work are highlighted. The case is made for NICE to move beyond its use of strict diagnostic categories and follow the lead of the American Psychological Association (APA) in adopting a pluralistic approach to psychotherapeutic and counselling research evidence.
No takes yet. Share an insight, caveat, or question.
Guy et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: